HUE064908T2 - Szubsztituált xantinszármazékok - Google Patents
Szubsztituált xantinszármazékokInfo
- Publication number
- HUE064908T2 HUE064908T2 HUE19820718A HUE19820718A HUE064908T2 HU E064908 T2 HUE064908 T2 HU E064908T2 HU E19820718 A HUE19820718 A HU E19820718A HU E19820718 A HUE19820718 A HU E19820718A HU E064908 T2 HUE064908 T2 HU E064908T2
- Authority
- HU
- Hungary
- Prior art keywords
- xanthine derivatives
- substituted xanthine
- substituted
- derivatives
- xanthine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212060 | 2018-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE064908T2 true HUE064908T2 (hu) | 2024-04-28 |
Family
ID=64665184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE19820718A HUE064908T2 (hu) | 2018-12-12 | 2019-12-10 | Szubsztituált xantinszármazékok |
Country Status (18)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064917B2 (en) | 2012-11-21 | 2024-08-20 | Stratasys, Inc. | Method for printing three-dimensional parts with cyrstallization kinetics control |
| IL283768B2 (en) * | 2018-12-12 | 2024-05-01 | Boehringer Ingelheim Int | Xanthine histories are transmuted |
| KR20250141831A (ko) * | 2023-02-08 | 2025-09-29 | 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 | 잔틴계 화합물 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX370372B (es) | 2013-03-15 | 2019-12-11 | Hydra Biosciences Inc | Xantinas sustituidas y metodos de uso de las mismas. |
| EP3180340B1 (en) | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| GB201702160D0 (en) | 2017-02-09 | 2017-03-29 | Univ Leeds Innovations Ltd | Inhibitors for use in therapy |
| JP7114702B2 (ja) * | 2017-07-11 | 2022-08-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規置換キサンチン誘導体 |
| IL283768B2 (en) * | 2018-12-12 | 2024-05-01 | Boehringer Ingelheim Int | Xanthine histories are transmuted |
-
2019
- 2019-12-10 IL IL283768A patent/IL283768B2/en unknown
- 2019-12-10 AU AU2019396499A patent/AU2019396499B2/en not_active Ceased
- 2019-12-10 JP JP2021533340A patent/JP7502299B2/ja active Active
- 2019-12-10 WO PCT/EP2019/084375 patent/WO2020120450A1/en not_active Ceased
- 2019-12-10 PL PL19820718.5T patent/PL3894410T3/pl unknown
- 2019-12-10 HU HUE19820718A patent/HUE064908T2/hu unknown
- 2019-12-10 ES ES19820718T patent/ES2964630T3/es active Active
- 2019-12-10 PH PH1/2021/551345A patent/PH12021551345A1/en unknown
- 2019-12-10 KR KR1020217021875A patent/KR102877857B1/ko active Active
- 2019-12-10 EA EA202191588A patent/EA202191588A1/ru unknown
- 2019-12-10 BR BR112021008316-2A patent/BR112021008316A2/pt unknown
- 2019-12-10 EP EP19820718.5A patent/EP3894410B1/en active Active
- 2019-12-10 CN CN201980081737.1A patent/CN113166151B/zh active Active
- 2019-12-10 MX MX2021007019A patent/MX2021007019A/es unknown
- 2019-12-10 DK DK19820718.5T patent/DK3894410T3/da active
- 2019-12-11 US US16/710,887 patent/US11198696B2/en active Active
- 2019-12-12 TW TW108145593A patent/TWI825243B/zh active
-
2021
- 2021-06-09 CL CL2021001509A patent/CL2021001509A1/es unknown
- 2021-11-10 US US17/523,316 patent/US20220177479A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL3894410T3 (pl) | 2024-03-18 |
| ES2964630T3 (es) | 2024-04-08 |
| BR112021008316A2 (pt) | 2021-08-03 |
| KR20210102955A (ko) | 2021-08-20 |
| US11198696B2 (en) | 2021-12-14 |
| CN113166151A (zh) | 2021-07-23 |
| DK3894410T3 (da) | 2023-11-27 |
| IL283768A (en) | 2021-07-29 |
| CN113166151B (zh) | 2023-12-01 |
| TWI825243B (zh) | 2023-12-11 |
| JP7502299B2 (ja) | 2024-06-18 |
| CA3119229A1 (en) | 2020-06-18 |
| KR102877857B1 (ko) | 2025-10-29 |
| EP3894410B1 (en) | 2023-10-11 |
| EP3894410A1 (en) | 2021-10-20 |
| TW202039495A (zh) | 2020-11-01 |
| US20200190093A1 (en) | 2020-06-18 |
| MX2021007019A (es) | 2021-09-10 |
| IL283768B1 (en) | 2024-01-01 |
| US20220177479A1 (en) | 2022-06-09 |
| WO2020120450A1 (en) | 2020-06-18 |
| CL2021001509A1 (es) | 2021-12-17 |
| PH12021551345A1 (en) | 2022-05-11 |
| AU2019396499A1 (en) | 2021-05-27 |
| AU2019396499B2 (en) | 2024-10-10 |
| IL283768B2 (en) | 2024-05-01 |
| JP2022512373A (ja) | 2022-02-03 |
| EA202191588A1 (ru) | 2021-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| IL271607B1 (en) | New azaquinoline histories | |
| PL4073065T3 (pl) | Nowe pochodne metylochinazolinonu | |
| HUE070924T2 (hu) | 2-Hidroxicikloalkán-1-karbamoil-származékok | |
| IL283990A (en) | Modified oxopyridine derivatives | |
| IL290815A (en) | History of alpha-d-galactopyranoside | |
| PL4077334T3 (pl) | Pochodne furoindazolu | |
| IL271799A (en) | New transmuted xanthine histories | |
| ZA202106024B (en) | Heterocyclic derivatives | |
| IL276592A (en) | History of Subtirum | |
| SG11202012594RA (en) | Spirochromane derivatives | |
| SI3796975T1 (sl) | Derivati sulfonilaminobenzamida | |
| IL279939A (en) | History of thiadiazine | |
| ZA201801718B (en) | Hydroxyalkyl thiadiazole derivatives | |
| PL3894410T3 (pl) | Podstawione pochodne ksantyny | |
| GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
| PL3770162T3 (pl) | Pochodne dihydrochromenu | |
| SG11202006837XA (en) | Dihydroindolizinone derivative | |
| IL255829B (en) | Xanthine derivative | |
| ZA202200181B (en) | 2-hydroxycycloalkane-1-carbamoyl derivatives | |
| GB201806948D0 (en) | Derivatives | |
| PT3319956T (pt) | Derivados de oxopiridina substituída |